Regenerative Therapy
Engineered bone-targeting particles reduced bone loss in mice
Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.
Mouse studyBone loss
Who was studiedOvariectomized female mice, against mice receiving non-targeted TPTD mRNA exosomes
What changedBone density was higher in mice receiving bone-targeting particles than in mice receiving non-targeted particles
The catchOnly 6 mice per group received the exosome treatments or vehicle